跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ZOLINZA vorinostat 100 mg capsule bottle - TGA Drug Approval Details
Approvals
/
TGA
/
ZOLINZA vorinostat 100 mg capsule bottle
Approved
STANDARD
ZOLINZA vorinostat 100 mg capsule bottle
Merck Sharp & Dohme (Australia) Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
f1fd3a59b3067a52
Company
Merck Sharp & Dohme (Australia) Pty Ltd
Type
Standard
Approval Details
Approval Id
f1fd3a59b3067a52
Product Name
ZOLINZA vorinostat 100 mg capsule bottle
Artg Id
156430
Artg Name
ZOLINZA vorinostat 100 mg capsules
Sponsor
Merck Sharp & Dohme (Australia) Pty Ltd
Company Detail Path
/organization/merck-sharp-and-dohme-australia-pty-ltd
Artg Date
2009-12-17
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/5a6d79bfa653eb6199aa81a9c2ef3fae.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/339afb68e45b7131dc69e9ac49da8389.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
f1fd3a59b3067a52
Type
Standard
Back to TGA Approvals